SOMAÍ Pharmaceuticals

Cautiously optimistic is one way to look at former President Donald Trump’s electoral win among cannabis industry leaders, some of whom say they are balancing hope for reforms with concerns over regulatory clarity and state autonomy. As the industry awaits Trump's direction on cannabis...

SOMAÍ Pharmaceuticals has partnered with Georgelle Pharmaceutical Ltd. to bring an extensive range of cannabis-based medicines to Irish patients. This marks SOMAÍ's fifth international expansion, having already established operations in the UK, Australia, Germany, and Poland earlier this year....

SOMAÍ Pharmaceuticals, a Portugal-headquartered marijuana company has partnered with Cosma S.A., a Poland-based company focused on cannabis-based pharmaceutical advancements. Under this strategic partnership, Cosma is designated as the marketing authorization holder (MAH) for both Cosma and SOMAÍ's...

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s...

Over the last few years, medical marijuana has experienced significant breakthroughs across Europe as many countries recognize its benefits with several countries having decriminalized the possession of small amounts. Some three years ago, the European Court ruled against...

Over the last couple of years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the latest cannabis developments from the Netherlands, United Kingdom, Bailiwick of Guernsey, and Switzerland. Netherlands: Legal Cannabis Trial Program Kicks Off This Week...

SOMAÍ Pharmaceuticals Unipessoal LDA has entered into a two-year supply agreement with a Polish distributor Cosma Cannabis. Cosma produces medical-grade cannabis products for importation and distribution across Poland. The contract represents 1 million euros ($1.08 million) in sales for SOMA...

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) has entered into a five-year agreement with SOMAÍ Pharmaceuticals, to supply its operations in Portugal with EU-GMP certified CBD extracts from Colombia. With the first shipments under the agreement already completed, Clever Leaves...

Vertical integration in the cannabis industry is one of the most debated topics of the day across the sector. As part of America's piecemeal approach to state-level legalization, states can choose their regulations. In most cases, vertical integration is allowed, with some states requiring...

Annual cannabis vape sales continue to grow across many major markets–fueling demand and a growing eco-footprint. Rising consumer demand comes despite environmental concerns lobbed at various market aspects, from cultivation to packaging. Worries are exceptionally high on single-use...

The Swiss government confirmed that it will remove limitations on medical marijuana use, starting August 1st, 2022.  Medical marijuana patients are required to seek exceptional authorization from the health ministry to get medical cannabis prescriptions, which causes needless delays...

In the days leading up to the recent bear market entry, cannabis insiders provided Benzinga with varied opinions regarding the impact of inflation on the cannabis sector. As fears of skyrocketing inflation fueled the bear market, some remained optimistic about cannabis, even confident in...

Cannabis reform is heating up across the nation. With it comes a booming multinational market, including a projected $102 billion in sales by 2026, according to Prohibition Partners. Global reform efforts also received a late-in-the-year shot in the arm when Malta legalized possession of up to...

Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regulatory activity than the federal government. At the very least, they say that the industry has made advancements so far without the efforts of Capitol Hill....

Drug store giants are already establishing themselves in the CBD market. Major players, including Walgreens Boots Alliance Inc (NASDAQ: WBA), Rite Aid Corporation (NYSE: RAD) and CVS Health Corp (NYSE: CVS), entered the cannabis space in 2019. Today, an array of CBN-infused products are offered in...